Could Combo Inhalers Help the Asthma Gap?

inhaler2.jpg

Yesterday, I posted about some AAFA research on a perpetual problem in asthma treatment, the practice of stopping inhaled maintenance steroids when flare symptoms disappear.

Recent Cochrane studies point to a possible solution, though–a combination inhaler somewhat like Advair, except it contains a short-acting beta-agonist and low-dose steroid rather than a long-acting one. The formoterol/budesonide combo would, in my daughter’s case, be like having her current Flovent and Proventil inhalers in one delivery system, rather than two.

So not only would this development keep moderate-to-severe patients from stopping their maintenance meds when they feel better (the asthma “gap”), but it would also actually increase those meds the more they use their quick-relief inhalers – exactly when asthmatics need a bump in steroids most.

And adults in this study who used the combo inhaler had fewer hospitalizations than those using single inhaler therapy (the practice of using 2 separate inhalers).